Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

EARS2 significantly coexpresses with PALB2 in breast and pancreatic cancer

Cancer Treatment and Research Communications(2022)10.1016/j.ctarc.2022.100595Source: DataRank Database

EARS2 significantly coexpresses with PALB2 in breast and pancreatic cancer is a research paper published in Cancer Treatment and Research Communications (2022). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

hpa

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.52)OA: goldTopics (42)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Peter H. Rheinstein ORCID,Steven Lehrer ORCID

Live enrichment

PubMed:35779338 PMC:PMC9427692 OpenAlex:https://openalex.org/W4283700653

NIH HHS

Grant: S10 OD018522

NIH HHS

Grant: S10 OD026880

National Institutes of Health

Grant: 1S10OD026880-01

Big Omics Data Engine 2 Supercomputer

National Institutes of Health

Grant: 1S10OD018522-01

Transforming Genomics with 5 PB Big Omics Data Engine Cray CS300-AC Supercomputer

FWCI

1.52

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

goldLicense: cc-by

journalhttps://www.sciencedirect.com/science/article/pii/S2468294222000855/pdf

publisherhttps://www.sciencedirect.com/science/article/pii/S2468294222000855/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2468294222000855?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2468294222000855?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ctarc.2022.100595

Fields of Study

BRCA gene mutations in cancerCancer Mechanisms and TherapyPARP inhibition in cancer therapy0301 basic medicine03 medical and health sciences

MeSH Terms

Fanconi Anemia Complementation Group N ProteinBreast NeoplasmsFemaleHumansMastectomyNuclear ProteinsPancreatic NeoplasmsTumor Suppressor ProteinsHSP40 Heat-Shock Proteins

Keywords

PALB2Pancreatic cancerBreast cancerMedicineOncologyCancerCancer researchInternal medicineMutationBiologyGeneGermline mutationGeneticsOncogenesPam50Luminal B SubtypeTumor Suppressor ProteinsNeoplasms. Tumors. Oncology. Including cancer and carcinogensNuclear ProteinsBreast NeoplasmsHSP40 Heat-Shock ProteinsArticlePancreatic NeoplasmsHumansFemaleFanconi Anemia Complementation Group N ProteinRC254-282Mastectomy

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

EARS2 significantly coexpresses with PALB2 in breast and pancreatic cancer

FAIR Checklist

Authors (2)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)